EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family

Katsuhide Hayashi iD, Thomas Callahan iD, John Rickard, Arwa Younis iD, Bryan Baranowski, David Martin, Shady Nakhla iD, Chadi Tabaja, Bruce L Wilkoff iD

Europace · 2023

DOI: 10.1093/europace/euad345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2023. Verfasst von Katsuhide Hayashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Electrophysiology and Pacing Section, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue Desk J2-2, Cleveland, OH 44…. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Pacemaker, Artificial. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deb family endowed chair in Lead Management.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Transvenous lead extraction (TLE) of implantable cardioverter-defibrillator (ICD) leads is considered challenging. The structure of each ICD leads is variable between manufacturer and model families. The net impact of lead family on the safety and effectiveness of TLE is poorly characterized. We assessed the safety and efficacy of ICD TLE and the impact of manufacturer ICD model family on the outcomes. Methods and results The study cohort included all consecutive patients with ICD who underwent TLE between 2013 and 2022 and are enrolled in the Cleveland Clinic Prospective TLE Registry. A total of 885 ICD leads (median implant duration 8 years) in 810 patients were included. Complete ICD TLE success was achieved in 97.2% of the leads (n = 860) and in 98.0% of the patients (n = 794). Major complications occurred in 22 patients (2.7%). Complete procedural success rate varied by manufacturer and lead family; Medtronic 98.9%, Abbott 95.9%, Boston Scientific 95.0%, Biotronik 91.2%, P = 0.03, and Linox family leads had the lowest, 89.7% P = 0.02. Multivariable predictors of incomplete ICD lead removal included ICD lead age > 10 years and Linox family lead. Multivariable predictors of major complications included ICD lead age > 15 years and longer lead extraction time, and predictors of all-cause mortality within 30 days included lead extraction for infection, end-stage renal disease, and higher New York Heart Association functional class.

Conclusion

Complete and safe ICD lead removal rate by TLE is extremely high but varied by manufacturer and lead family. Linox family lead and >10 years lead age were independent predictors of incomplete lead removal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantablePacemaker, ArtificialHumansChildAdolescentProspective StudiesDevice RemovalRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

ComplicationsImplantable cardioverter-defibrillator leadIncomplete removalLead familyTransvenous lead extraction

Autor:innen und Institutionen

  • Cardiac Electrophysiology and Pacing Section, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue Desk J2-2, Cleveland, OH 44195, USA.

ORCID-Profile: Katsuhide Hayashi, Thomas Callahan, Arwa Younis, Shady Nakhla, Bruce L Wilkoff

Förderung

  • Deb family endowed chair in Lead Management

Zitieren

APA

Hayashi, K., Callahan, T., Rickard, J., Younis, A., Baranowski, B., Martin, D., Nakhla, S., Tabaja, C., & Wilkoff, B. L. (2023). Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family. Europace. https://doi.org/10.1093/europace/euad345

Vancouver

Hayashi K, Callahan T, Rickard J, Younis A, Baranowski B, Martin D, et al. Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family. Europace. 2023. doi:10.1093/europace/euad345

BibTeX
@article{Hayashi2023,
  author = {Hayashi, Katsuhide and Callahan, Thomas and Rickard, John and Younis, Arwa and Baranowski, Bryan and Martin, David and Nakhla, Shady and Tabaja, Chadi and Wilkoff, Bruce L},
  title = {Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family},
  journal = {Europace},
  year = {2023},
  doi = {10.1093/europace/euad345}
}
Kostenlos starten →